AbbVie insider trading
ABBVfinancial statementsForm 4 filings on EDGAR164 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at AbbVie bought $0 of stock in the open market, and 1 sold $8M. Officers and directors accounted for $0 of purchases and $8M of sales. The last reported transaction was an option exercise by Donoghoe Nicholas on August 14, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through August 18, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $8MAug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
164 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | option exercise | 32,710 | $79.02 | $3M | 107,140 | Aug 18, 2026 |
| Aug 14, 2026 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | open-market sale | 32,710 | $250.00 | $8M | 74,430 | Aug 18, 2026 |
| May 8, 2026 | Falk Thomas J | Director | award | 1,118 | $0.00 | — | 2,321 | May 12, 2026 |
| May 8, 2026 | Waddell Frederick H | Director | award | 1,118 | $0.00 | — | 30,076 | May 12, 2026 |
| May 8, 2026 | Roberts Rebecca B | Director | award | 1,118 | $0.00 | — | 14,846 | May 12, 2026 |
| May 8, 2026 | Rapp Edward J | Director | award | 1,118 | $0.00 | — | 45,964 | May 12, 2026 |
| May 8, 2026 | Quaggin Susan E | Director | award | 1,118 | $0.00 | — | 3,643 | May 12, 2026 |
| May 8, 2026 | Meyer Melody B | Director | award | 1,118 | $0.00 | — | 17,616 | May 12, 2026 |
| May 8, 2026 | Hart Brett J | Director | award | 1,118 | $0.00 | — | 20,590 | May 12, 2026 |
| May 8, 2026 | Freyman Thomas C | Director | award | 1,118 | $0.00 | — | 127,869 | May 12, 2026 |
| May 8, 2026 | Davis Jennifer L. | Director | award | 1,118 | $0.00 | — | 3,643 | May 12, 2026 |
| May 8, 2026 | Burnside William H.L. | Director | award | 1,118 | $0.00 | — | 28,076 | May 12, 2026 |
| May 8, 2026 | Austin Roxanne S | Director | award | 1,118 | $0.00 | — | 39,576 | May 12, 2026 |
| Mar 4, 2026 | Purdue David Ryan | SVP, Controller | open-market sale | 5,230 | $233.56 | $1M | 2,654 | Mar 6, 2026 |
| Mar 2, 2026 | Siatis Perry C | EVP, GC AND SECRETARY | open-market sale10b5-1 | 10,291 | $234.66 | $2M | 7,219 | Mar 3, 2026 |
| Mar 2, 2026 | Siatis Perry C | EVP, GC AND SECRETARY | open-market sale10b5-1 | 2,600 | $235.26 | $612K | 4,619 | Mar 3, 2026 |
| Mar 2, 2026 | Siatis Perry C | EVP, GC AND SECRETARY | open-market sale10b5-1 | 5,777 | $233.51 | $1M | 17,510 | Mar 3, 2026 |
| Feb 27, 2026 | Purdue David Ryan | SVP, Controller | tax withholding | 2,108 | $232.08 | $489K | 8,468 | Mar 11, 2026 |
| Feb 27, 2026 | Crum Demetris D | EVP, CHIEF HR OFFICER | tax withholding | 1,594 | $232.08 | $370K | 7,914 | Mar 6, 2026 |
| Feb 27, 2026 | Thakkar Roopal | EVP, R&D and CSO | tax withholding | 8,037 | $232.08 | $2M | 52,376 | Mar 3, 2026 |
| Feb 27, 2026 | Michael Robert A. | CHAIRMAN OF THE BOARD AND CEO, Director | tax withholding | 36,523 | $232.08 | $8M | 178,737 | Mar 3, 2026 |
| Feb 27, 2026 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | tax withholding | 23,812 | $232.08 | $6M | 83,171 | Mar 3, 2026 |
| Feb 27, 2026 | Siatis Perry C | EVP, GC AND SECRETARY | tax withholding | 14,850 | $232.08 | $3M | 23,287 | Mar 3, 2026 |
| Feb 27, 2026 | Saleki-Gerhardt Azita | EVP, CHIEF OPERATIONS OFFICER | tax withholding | 16,309 | $232.08 | $4M | 197,794 | Mar 3, 2026 |
| Feb 27, 2026 | Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | tax withholding | 21,638 | $232.08 | $5M | 38,777 | Mar 3, 2026 |
| Feb 27, 2026 | Purdue David Ryan | SVP, Controller | tax withholding | 2,692 | $232.08 | $625K | 7,884 | Mar 3, 2026 |
| Feb 27, 2026 | Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | tax withholding | 12,874 | $232.08 | $3M | 74,430 | Mar 3, 2026 |
| Feb 25, 2026 | Siatis Perry C | EVP, GC AND SECRETARY | option exercise | 7,292 | $192.86 | $1M | 60,518 | Feb 27, 2026 |
| Feb 25, 2026 | Siatis Perry C | EVP, GC AND SECRETARY | option exercise | 7,314 | $149.62 | $1M | 45,451 | Feb 27, 2026 |
| Feb 25, 2026 | Siatis Perry C | EVP, GC AND SECRETARY | option exercise | 7,775 | $175.28 | $1M | 53,226 | Feb 27, 2026 |
| Feb 25, 2026 | Siatis Perry C | EVP, GC AND SECRETARY | open-market sale10b5-1 | 22,381 | $230.00 | $5M | 38,137 | Feb 27, 2026 |
| Feb 18, 2026 | Thakkar Roopal | EVP, R&D and CSO | award | 6,015 | $0.00 | — | 48,291 | Feb 20, 2026 |
| Feb 18, 2026 | Thakkar Roopal | EVP, R&D and CSO | award | 6,638 | $0.00 | — | 60,413 | Feb 20, 2026 |
| Feb 18, 2026 | Thakkar Roopal | EVP, R&D and CSO | award | 3,346 | $0.00 | — | 53,775 | Feb 20, 2026 |
| Feb 18, 2026 | Thakkar Roopal | EVP, R&D and CSO | award | 2,138 | $0.00 | — | 50,429 | Feb 20, 2026 |
| Feb 18, 2026 | Purdue David Ryan | SVP, Controller | award | 1,292 | $0.00 | — | 9,192 | Feb 20, 2026 |
| Feb 18, 2026 | Purdue David Ryan | SVP, Controller | award | 1,384 | $0.00 | — | 10,576 | Feb 20, 2026 |
| Feb 18, 2026 | Purdue David Ryan | SVP, Controller | award | 2,505 | $0.00 | — | 7,010 | Feb 20, 2026 |
| Feb 18, 2026 | Purdue David Ryan | SVP, Controller | award | 890 | $0.00 | — | 7,900 | Feb 20, 2026 |
| Feb 18, 2026 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | award | 9,266 | $0.00 | — | 88,563 | Feb 20, 2026 |
| Feb 18, 2026 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | award | 9,432 | $0.00 | — | 97,995 | Feb 20, 2026 |
| Feb 18, 2026 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | award | 8,988 | $0.00 | — | 106,983 | Feb 20, 2026 |
| Feb 18, 2026 | Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | award | 26,063 | $0.00 | — | 79,297 | Feb 20, 2026 |
| Feb 18, 2026 | Siatis Perry C | EVP, GC AND SECRETARY | award | 5,808 | $0.00 | — | 38,137 | Feb 20, 2026 |
| Feb 18, 2026 | Siatis Perry C | EVP, GC AND SECRETARY | award | 16,290 | $0.00 | — | 20,909 | Feb 20, 2026 |
| Feb 18, 2026 | Siatis Perry C | EVP, GC AND SECRETARY | award | 5,628 | $0.00 | — | 32,329 | Feb 20, 2026 |
| Feb 18, 2026 | Siatis Perry C | EVP, GC AND SECRETARY | award | 5,792 | $0.00 | — | 26,701 | Feb 20, 2026 |
| Feb 18, 2026 | Saleki-Gerhardt Azita | EVP, CHIEF OPERATIONS OFFICER | award | 6,058 | $0.00 | — | 200,391 | Feb 20, 2026 |
| Feb 18, 2026 | Saleki-Gerhardt Azita | EVP, CHIEF OPERATIONS OFFICER | award | 17,041 | $0.00 | — | 194,333 | Feb 20, 2026 |
| Feb 18, 2026 | Saleki-Gerhardt Azita | EVP, CHIEF OPERATIONS OFFICER | award | 7,074 | $0.00 | — | 207,465 | Feb 20, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Siatis Perry C | EVP, GC AND SECRETARY | Mar 2, 2026 | open-market sale | 7,219 | — | $10M (4) | 4 of 4 |
| Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Aug 14, 2026 | option exercise | 107,140 | — | $8M (1) | 0 of 1 |
| Purdue David Ryan | SVP, Controller | Mar 4, 2026 | open-market sale | 2,654 | — | $1M (1) | 0 of 1 |
| Richmond Timothy J. | EVP, CHIEF HR OFFICER | Mar 3, 2025 | open-market sale | 21,703 | — | — | — |
| Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | Feb 27, 2026 | tax withholding | 83,171 | — | — | — |
| Saleki-Gerhardt Azita | EVP, CHIEF OPERATIONS OFFICER | Feb 27, 2026 | tax withholding | 197,794 | — | — | — |
| Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | Feb 27, 2026 | tax withholding | 38,777 | — | — | — |
| Buckbee Kevin K | SVP, CONTROLLER | Feb 28, 2025 | tax withholding | 7,797 | — | — | — |
| Thakkar Roopal | EVP, R&D and CSO | Feb 27, 2026 | tax withholding | 52,376 | — | — | — |
| Michael Robert A. | CHAIRMAN OF THE BOARD AND CEO, Director | Feb 27, 2026 | tax withholding | 178,737 | — | — | — |
| Gonzalez Richard A | Director | Mar 31, 2025 | gift | 386,479 | — | — | — |
| Crum Demetris D | EVP, CHIEF HR OFFICER | Feb 27, 2026 | tax withholding | 7,914 | — | — | — |
| Falk Thomas J | Director | May 8, 2026 | award | 2,321 | — | — | — |
| Waddell Frederick H | Director | May 8, 2026 | award | 30,076 | — | — | — |
| Roberts Rebecca B | Director | May 8, 2026 | award | 14,846 | — | — | — |
| Rapp Edward J | Director | May 8, 2026 | award | 45,964 | — | — | — |
| Quaggin Susan E | Director | May 8, 2026 | award | 3,643 | — | — | — |
| Meyer Melody B | Director | May 8, 2026 | award | 17,616 | — | — | — |
| Hart Brett J | Director | May 8, 2026 | award | 20,590 | — | — | — |
| Freyman Thomas C | Director | May 8, 2026 | award | 127,869 | — | — | — |
| Davis Jennifer L. | Director | May 8, 2026 | award | 3,643 | — | — | — |
| Burnside William H.L. | Director | May 8, 2026 | award | 28,076 | — | — | — |
| Austin Roxanne S | Director | May 8, 2026 | award | 39,576 | — | — | — |
| Tilton Glenn F | Director | May 9, 2025 | award | 51,564 | — | — | — |
| Alpern Robert J | Director | May 9, 2025 | award | 35,646 | — | — | — |
Questions
Are AbbVie insiders buying or selling?
Over the twelve months to November 1, 2026, 3 insiders at AbbVie sold $19M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $19M. Only open-market purchases and sales are counted.
Who sold the most AbbVie stock in the last year?
Siatis Perry C (EVP, GC AND SECRETARY) sold $10M in 4 open-market sales over the twelve months to November 1, 2026.
Do AbbVie executives sell under 10b5-1 plans?
4 of the 6 open-market sales in the last twelve months (67%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on AbbVie
- AbbVie financial statements
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.